Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:2 Issue:4 Number:96 ISSN#:2563-5476
Author Verified
ACE Report #406
Ace Report Cover General Orthopaedics

Golimumab treatment provides superior treatment of rheumatoid arthritis

How to Cite

OrthoEvidence. Golimumab treatment provides superior treatment of rheumatoid arthritis . ACE Report. 2013;2(4):96. Available from: https://myorthoevidence.com/AceReport/Report/406

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): A multicentre, randomised, double-blind, placebo-controlled, phase III trial

Lancet. 2009 Jul 18;374(9685):210-21. Epub 2009 Jun 26

Contributing Authors: JS Smolen J Kay MK Doyle R Landewé EL Matteson J Wollenhaupt N Gaylis FT Murphy JS Neal Y Zhou S Visvanathan EC Hsia MU Rahman GO-AFTER study investigators

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


461 patients with rheumatoid arthritis who have undergone treatment with a TNF-alpha inhibitor previously were randomized to three groups. 2 groups were treated with either a 50 mg or 100 mg dosage of Golimumab and the third group received a placebo injection. The results indicated that treatment with Golimumab at either dose provided significant improvements in rheumatoid arthritis measures (ARC2...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.